Обзор компании

Альбом компании31

Основная информация
Nanjing Liming Bio-Products Co., Ltd. is specialized in the development, manufacture and marketing of a series of rapid test equipment of Sexually transmitted diseases (STDs), Gastroenteritic diseases and Fertility. Founded in June, 2001, we have abundant experience in the field of diagnostics, especially for STDs. Our technical team began application research on colored latex chromatography technology in 2002 and we have gained many achievements, such as HSV 1/2 antigen rapid test, HPV rapid test, Chlamydia/Gonorrhea combo rapid test, Trichomonas/Candida combo rapid test and so on.We strictly abide by the requirements of ISO13485, establishing a stringent Quality Management system covering from laboratory research to clinical trials and mass production. We also formulate a set of technical and detailed SOP for manufacturing to ensure the controllability & efficiency of our products.Our tenet is "outstanding performance has been lab-proved compared to other methods (including PCR or culture) which are time-consuming and costly". Using our rapid tests, we can save a lot of time of waiting because it just needs 10 minutes.For many years, we have been dedicated to our mission of "provide rapid, accurate and cost-effective STDs diagnostic tests through ceaseless efforts on the diagnostic research and development". We are looking forward to establishing relationships with you in the near future.
  • Транзакции
    -
  • Время отклика
    >24h
  • Частота откликов
    0%
Тип компании
Производитель, Торговая компания
Страна / Регион
Jiangsi, China
Основные продуктыВсего сотрудников
51 - 100 People
Общий годовой доход
Below US$1 Million
Год основания
2001
Сертификаты
-
Сертификаты на продукцию(1)
Патенты
-
Товарные знаки(1)
Основные рынки

Емкость продукта

Информация о заводе

Размер завода
Below 1,000 square meters
Местоположение завода
No.12 Huayuan Road, Nanjing, Jiangsu
Число производственных линий
5
Контрактное производство
OEM Service Offered, Design Service Offered, Buyer Label Offered
Годовой выпуск
US$2.5 Million - US$5 Million